Celemics, Inc. (KOSDAQ:331920)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,830
-1,050 (-5.87%)
At close: Apr 28, 2026
463.82%
Market Cap 137.40B
Revenue (ttm) 5.77B
Net Income (ttm) -4.04B
Shares Out 8.16M
EPS (ttm) -494.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 201,699
Average Volume 305,754
Open 18,780
Previous Close 17,880
Day's Range 16,500 - 18,780
52-Week Range 2,535 - 19,840
Beta -0.58
RSI 60.11
Earnings Date Apr 3, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 331920
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.